SEC Company Response from CV Sciences, Inc. (CVSI) (CIK 0001510964) (CVSI) — Apr 28, 2020
CV Sciences, Inc. (CVSI) (CIK 0001510964)
Date: April 28, 2020 · CIK: 0001510964 · Accession: 0001510964-20-000037
AI Filing Summary & Sentiment
File numbers found in text: 333-237772
Letter
VIA EDGAR Office of Life Sciences Division of Corporation Finance Washington, D.C. 20549 Re: CV Sciences, Inc. Registration Statement on Form S-3 File No. 333-237772
Dear Mr. Gabor:
Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of CV Sciences, Inc., respectfully requests that the effective date of the Registration Statement on Form S-3 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on April 30, 2020, or as soon as practicable thereafter.
If you have any questions or require additional information, please contact Craig M. Garner, Esq. of Latham & Watkins LLP at (858) 523-5407. Thank you for your assistance and cooperation in this matter.
Very truly yours,
CV SCIENCES, INC.
Show Raw Text
CORRESP 1 filename1.htm Document April 28, 2020 VIA EDGAR Mr. Jeffrey Gabor Office of Life Sciences Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: CV Sciences, Inc. Registration Statement on Form S-3 File No. 333-237772 Dear Mr. Gabor: Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of CV Sciences, Inc., respectfully requests that the effective date of the Registration Statement on Form S-3 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on April 30, 2020, or as soon as practicable thereafter. If you have any questions or require additional information, please contact Craig M. Garner, Esq. of Latham & Watkins LLP at (858) 523-5407. Thank you for your assistance and cooperation in this matter. Very truly yours, CV SCIENCES, INC. By: /s/ Joseph D. Dowling Joseph D. Dowling Chief Executive Officer cc: Joerg Grasser, CV Sciences, Inc. Craig M. Garner, Esq., Latham & Watkins LLP